Recent Finacing
Recent Raise
ATANIS Biotech operates FAST‑PASE, an in vitro lab testing platform that mimics allergic reactions for preclinical drug development and QC testing, serving pharma, biotech, and research groups.
Focus Areas
Recent Investors
Funding round
Investors
